News | Computed Tomography (CT) | November 21, 2019

FDA Clears Siemens Healthineers Somatom X.cite CT Scanner

Somatom X.cite improves patient comfort with an 82 cm gantry bore and delivers powerful performance with Vectron tube

The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source computed tomography (CT) scanner from Siemens Healthineers together with the new myExam Companion intelligent user interface concept

November 21, 2019 — The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source computed tomography (CT) scanner from Siemens Healthineers together with the new myExam Companion intelligent user interface concept. The intuitive user interface of the myExam Companion guides the user through the exam workflow with precise questions about the patient, potentially enabling optimization of the state-of-the-art features of a premium CT scanner such as the Somatom X.cite. The myExam Companion combines available patient data such as gender and age with other user or machine-observable, patient-specific information – for example, a patient’s electrocardiogram (ECG) waveform for a cardiac study – to identify optimal acquisition and reconstruction techniques for each patient. Together, these innovations make the imaging process more efficient, compensating for differences in user experience levels and scan complexities on even the most complicated acquisitions, including coronary CT angiography (CTA) studies.

The first CT scanner launching with the myExam Companion intelligent user interface concept, the Somatom X.cite uses the Vectron X-ray tube, which was previously available only on the Somatom Force dual source CT scanner. In combination with a large 82cm gantry bore, the Somatom X.cite offers advanced imaging capabilities with an even greater focus on patient comfort.

myExam Companion

The myExam Companion enables technologists to utilize the full potential of not only the Somatom X.cite, but also the scanners of the Somatom go. CT platform.¹ Siemens Healthineers analyzed nearly 200,000 scan protocols using artificial intelligence and tapped clinical experts to identify key questions regarding the framework conditions for an optimized scan result. On this basis, Siemens Healthineers designed scan strategies and clinical decision trees to aid in proper setup and scanner operation. At its core, the myExam Companion renders complicated clinical decision-making into these 20-plus, user-definable clinical decision trees that are displayed at the human-machine interface, either at the operator console or using the scanner’s mobile, detachable tablets. These clinical decision tree workflows are sharable across the institution.

"Lack of staff and time and the creation of standards are some of the biggest hurdles in the daily business of radiology,” says André Hartung, president of Diagnostic Imaging at Siemens Healthineers. “With the SOMATOM X.cite and the myExam Companion, we provide our customers with unique tools to overcome these hurdles effectively. It is a major step for our imaging portfolio into the world of intelligent user support and for Siemens Healthineers on our way to becoming a leader in clinical decision support."

Somatom X.cite

In addition to its large, 82 cm gantry bore and optional Moodlight feature, the Somatom X.cite includes the Patient Observation Camera. This new 2-D visualization camera allows the technologist to closely monitor the patient while he or she is inside the gantry for potentially fewer patient motion artifacts. The Somatom X.cite also includes Visual Patient Instruction, a new visual breath hold indicator on the gantry that guides the patient through the breath hold process with color-guided visual instructions.

Together, these features create a holistic, patient-centric scanning experience.

The technologist can control scan preparation and oversee the scan via a detachable, gantry-mounted tablet, enabling the technologist to remain with the patient until immediately before the scan. An optional FAST Integrated Workflow with FAST 3D Positioning Camera collects further anatomical information and automatically positions the patient at isocenter. The Vectron X-ray tube enables a maximum 1,200 mA High Power mode at low 70 or 80 kV stations; low kV scanning with significant power reserves enables lowering of radiation dose and contrast media volumes. Together with the Stellar Infinity detector, the Vectron tube enables visualization of even the smallest details with 0.30 mm precision resolution. To further personalize the scanning process, the Somatom X.cite is capable of fine-tuned 10 kV steps, enabling a greater range of personalized dose modulation.

The Somatom X.cite CT scanner with the myExam Companion intelligent user interface concept will be displayed at the Siemens Healthineers booth (7530) at the 105th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Dec. 1-7 at McCormick Place in Chicago.

¹ The SOMATOM.go systems with my Exam Companion are pending 510(k) clearance, and are not yet commercially available in the United States.

For more information: http://siemens-healthineers.us/somatom-xcite

Related Content

AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

Feature | CT Angiography (CTA) | October 23, 2020
October 22, 2020 – In the FORECAST randomized clinical trial, the use of ...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe.

A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | October 22, 2020
October 22, 2020 — According to an open-...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News
Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos